MILAN, Italy--(BUSINESS WIRE)--Sorin Group (MIL:SRN) (Reuters code: SORN.MI) announced today that it has entered into a binding Asset Purchase Agreement for the purchase of the Clearglide(R) endoscopic vessel harvesting product line from Datascope Inc. (NASDAQ:DSCP - News). Further terms of the transaction were not disclosed. The transaction is contingent on the closing of the acquisition of Datascope by Getinge AB, satisfaction of typical contractual conditions, and satisfaction of anti-trust procedures in the United States.
The vessel harvesting product line will, upon closing of the transaction, be integrated into Sorin Group’s Cardiopulmonary Business Unit.
Endoscopic vessel harvesting (‘EVH’) devices enable less-invasive techniques for the harvesting of suitable vessels for use in conjunction with coronary artery bypass grafting. EVH procedures replace traditional open vessel harvesting and avoid significant pain and discomfort for patients during the recovery period.
About the Sorin Group
The Sorin Group (www.sorin.com), a world leader in the development of medical technologies for cardiac surgery, offers innovative therapies for cardiac rhythm dysfunctions, interventional cardiology, and the treatment of chronic kidney diseases. At the Sorin Group, more than 4,000 employees work to serve over 5,000 public and private treatment centers. Every year, over 1 million patients are treated with the devices of Sorin Group in more than 80 countries. For more information, please visit: www.sorin.com
Director, Corporate Communications
Tel: +33 (0)1 46 01 33 78
Mobile: +33 (0)6 76 12 67 73
Tel: +39 02 69969716
Source: Sorin Group